- Martínez-López S, Sarriá B, Gómez-Juaristi M, Goya L, Mateos R, Bravo-Clemente L: Theobromine, caffeine, and theophylline metabolites in human plasma and urine after consumption of soluble cocoa products with different methylxanthine contents Food Research International. 2014 March 14;63:446-455.
- Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR: Absorption rate of methylxanthines following capsules, cola and chocolate. Eur J Clin Pharmacol. 1996;51(3-4):319-25. doi: 10.1007/s002280050205. [PubMed:9010706 ]
- Richelle M, Tavazzi I, Enslen M, Offord EA: Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr. 1999 Jan;53(1):22-6. doi: 10.1038/sj.ejcn.1600673. [PubMed:10048796 ]
- Martinez-Lopez S, Sarria B, Baeza G, Mateos R, Bravo-Clemente L: Pharmacokinetics of caffeine and its metabolites in plasma and urine after consuming a soluble green/roasted coffee blend by healthy subjects. Food Res Int. 2014 Oct;64:125-133. doi: 10.1016/j.foodres.2014.05.043. Epub 2014 Jun 11. [PubMed:30011631 ]
- Lelo A, Birkett DJ, Robson RA, Miners JO: Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986 Aug;22(2):177-82. doi: 10.1111/j.1365-2125.1986.tb05246.x. [PubMed:3756065 ]
- Tarka SM Jr, Arnaud MJ, Dvorchik BH, Vesell ES: Theobromine kinetics and metabolic disposition. Clin Pharmacol Ther. 1983 Oct;34(4):546-55. doi: 10.1038/clpt.1983.212. [PubMed:6617078 ]
- Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM: Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine. J Clin Pharmacol. 1999 Mar;39(3):252-9. [PubMed:10073324 ]
- Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S: Caffeine disposition after oral doses. Clin Pharmacol Ther. 1982 Jul;32(1):98-106. doi: 10.1038/clpt.1982.132. [PubMed:7083737 ]
- Blanchard J, Sawers SJ, Jonkman JH, Tang-Liu DD: Comparison of the urinary metabolite profile of caffeine in young and elderly males. Br J Clin Pharmacol. 1985 Feb;19(2):225-32. doi: 10.1111/j.1365-2125.1985.tb02635.x. [PubMed:3986081 ]
- Carrillo JA, Benitez J: Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clin Pharmacol Ther. 1994 Mar;55(3):293-304. doi: 10.1038/clpt.1994.30. [PubMed:8143395 ]
- Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ: Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther. 2007 Jul;82(1):54-62. doi: 10.1038/sj.clpt.6100211. Epub 2007 Apr 18. [PubMed:17443132 ]
- Jeppesen U, Loft S, Poulsen HE, Brsen K: A fluvoxamine-caffeine interaction study. Pharmacogenetics. 1996 Jun;6(3):213-22. doi: 10.1097/00008571-199606000-00003. [PubMed:8807660 ]
- Grant DM, Tang BK, Kalow W: Variability in caffeine metabolism. Clin Pharmacol Ther. 1983 May;33(5):591-602. doi: 10.1038/clpt.1983.80. [PubMed:6687705 ]
- Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 Aug;37(8):693-703. doi: 10.1002/j.1552-4604.1997.tb04356.x. [PubMed:9378841 ]
- Rodopoulos N, Norman A: Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites. Scand J Clin Lab Invest. 1996 May;56(3):259-68. doi: 10.3109/00365519609088615. [PubMed:8761530 ]
- Lang R, Dieminger N, Beusch A, Lee YM, Dunkel A, Suess B, Skurk T, Wahl A, Hauner H, Hofmann T: Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem. 2013 Oct;405(26):8487-503. doi: 10.1007/s00216-013-7288-0. Epub 2013 Aug 28. [PubMed:23982107 ]